Profil
Nicholas Brandon is currently Chief Scientific Officer at Neumora Therapeutics, Inc. since 2022.
Formerly, Dr. Brandon was Senior Vice President & Head-Biology at Jnana Therapeutics, Inc. from 2019 to 2020 and held the position of Head-Neuroscience Discovery at AstraZeneca PLC.
Education includes a doctorate from University College London and an undergraduate degree from Pembroke College Cambridge.
Aktiva positioner av Nicholas Brandon
| Företag | Position | Start |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-04-01 |
Tidigare kända positioner av Nicholas Brandon
| Företag | Position | Slut |
|---|---|---|
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Företagsledare/Principal | 2020-04-01 |
| ASTRAZENECA PLC | Företagsledare/Principal | - |
Nicholas Brandons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pembroke College Cambridge
Pembroke College Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Health Technology |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
















